Transcriptomic profiling of endothelial progenitor cells in post-COVID-19 patients: Insights at 3- and 6-month post-infection

Puntos clave

• Endothelial progenitor cells exhibit significant transcriptomic changes at 3 and 6 months post-COVID-19 infection.
• Key biomarkers identified show alterations in cellular responses, highlighting potential complications.
• Assessment focus includes transcriptomic profiling to understand long-term effects of COVID-19.
• Insights from this work may enable better monitoring and therapeutic strategies for post-COVID-19 patients.